1. Home
  2. BHB vs NNNN Comparison

BHB vs NNNN Comparison

Compare BHB & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHB
  • NNNN
  • Stock Information
  • Founded
  • BHB 1887
  • NNNN 2021
  • Country
  • BHB United States
  • NNNN Germany
  • Employees
  • BHB N/A
  • NNNN N/A
  • Industry
  • BHB Major Banks
  • NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • BHB Finance
  • NNNN Health Care
  • Exchange
  • BHB Nasdaq
  • NNNN Nasdaq
  • Market Cap
  • BHB 436.5M
  • NNNN 369.6M
  • IPO Year
  • BHB 1997
  • NNNN 2025
  • Fundamental
  • Price
  • BHB $31.65
  • NNNN $47.25
  • Analyst Decision
  • BHB Hold
  • NNNN
  • Analyst Count
  • BHB 2
  • NNNN 0
  • Target Price
  • BHB $33.00
  • NNNN N/A
  • AVG Volume (30 Days)
  • BHB 44.1K
  • NNNN 229.6K
  • Earning Date
  • BHB 07-21-2025
  • NNNN 01-01-0001
  • Dividend Yield
  • BHB 4.04%
  • NNNN N/A
  • EPS Growth
  • BHB 3.26
  • NNNN N/A
  • EPS
  • BHB 2.84
  • NNNN 0.06
  • Revenue
  • BHB $149,882,000.00
  • NNNN $8,185,146.00
  • Revenue This Year
  • BHB $18.22
  • NNNN N/A
  • Revenue Next Year
  • BHB $13.38
  • NNNN N/A
  • P/E Ratio
  • BHB $11.15
  • NNNN $873.07
  • Revenue Growth
  • BHB 2.29
  • NNNN 21.95
  • 52 Week Low
  • BHB $26.43
  • NNNN $5.18
  • 52 Week High
  • BHB $38.47
  • NNNN $53.61
  • Technical
  • Relative Strength Index (RSI)
  • BHB 59.50
  • NNNN N/A
  • Support Level
  • BHB $31.23
  • NNNN N/A
  • Resistance Level
  • BHB $32.42
  • NNNN N/A
  • Average True Range (ATR)
  • BHB 0.71
  • NNNN 0.00
  • MACD
  • BHB 0.21
  • NNNN 0.00
  • Stochastic Oscillator
  • BHB 75.12
  • NNNN 0.00

About BHB Bar Harbor Bankshares Inc.

Bar Harbor Bankshares Inc is a bank holding company along with its subsidiaries that offers a full range of financial services products, brokerage services through third-party brokerage arrangements and also trust and investment management services to individuals, businesses, non-profit organizations, and municipalities. The company has following reportable segments such as Commercial construction, Commercial real estate owner occupied and non-owner occupied, Tax Exempt, Commercial and industrial loans, Residential real estate, Home equity and Consumer other. Its products and services consist of checking, deposits, cards, mobile banking, online services, loans, merchant services, trust, and fiduciary services, investment planning, education funding, individual retirement planning..

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: